403
Sorry!!
Error! We're sorry, but the page you were looking for doesn't exist.
Qatar, Turkey ink deal of biotech drugs
(MENAFN) Qatar's massive firm, Ebn Sina Medical, stated that it made a distribution agreement with Turkish Company, CinnaGen Ilac, to import biotech drugs, local media reported, Tuesday.
The biotech drugs, which will be exported from Turkey to Qatar, are used for multiple sclerosis, rheumatoid arthritis, cancer and blood diseases.
"I am pleased to announce this partnership, with a leading pharmaceutical firm, such as, CinnaGen Ilac. As we reveal this agreement, we express our determination and commitment, to secure medicine availability in Qatar,'' said Sherif Shehata, general manager of Ebn Sina Medical.
Attended by the chief executive officers of both companies, in addition to the Turkish envoy to Qatar, the signing took place on Monday in Doha.
The biotech drugs, which will be exported from Turkey to Qatar, are used for multiple sclerosis, rheumatoid arthritis, cancer and blood diseases.
"I am pleased to announce this partnership, with a leading pharmaceutical firm, such as, CinnaGen Ilac. As we reveal this agreement, we express our determination and commitment, to secure medicine availability in Qatar,'' said Sherif Shehata, general manager of Ebn Sina Medical.
Attended by the chief executive officers of both companies, in addition to the Turkish envoy to Qatar, the signing took place on Monday in Doha.
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Most popular stories
Market Research
More Story
Comments
No comment